DNAH5

DNAH5 encodes an axonemal outer dynein arm (ODA) heavy chain that powers ciliary motility, and its loss causes primary ciliary dyskinesia (PCD) with randomization of left-right body asymmetry (PMID:11788826, PMID:11062149). The protein localizes in a defined regional pattern along the ciliary axoneme, where DNAH5 and DNAH9 occupy distinct domains and define at least two ODA subtypes (PMID:15750039). Loss-of-function mutations cluster in a small set of exons and account for a major share of ODA-defective PCD; in mutant cells DNAH5 fails to assemble into the axoneme and instead accumulates at the microtubule-organizing center, with complete absence yielding immotile cilia and distal-only absence permitting residual motility (PMID:15750039, PMID:16627867). This mislocalization is specific to the primary defect and is not induced by inflammatory or IL-13-driven secondary ciliary dyskinesia (PMID:16492982). The disease mechanism for laterality defects was established in Dnah5 mutant mice, in which left-right organizer monocilia lack ODAs, fail to generate leftward fluid flow, and randomize the Nodal signaling cascade during embryogenesis (PMID:31638833). Separately, a recurrent TRA2B-DNAH5 gene fusion identified in lung squamous cell carcinoma acts as an oncogenic driver via a SIRT6-ERK1/2-MMP1 signaling axis (PMID:27670699).

1. 2000 Medium

   Establishing a genomic locus for a Chlamydomonas-related dynein heavy chain was the first step in linking DNAH5 to ciliary motility disease, before any causal mutation was known.

   Evidence Genome-wide homozygosity mapping in a consanguineous PCD family with ODA absence on electron microscopy

   PMID:11062149

   Open questions at the time

   • Single family, candidate-gene status only
   • No causative mutation demonstrated
   • No direct protein localization shown
2. 2002 High

   Identifying loss-of-function mutations in PCD patients with laterality randomization established DNAH5 as an essential ODA heavy chain required for ciliary motility and left-right asymmetry.

   Evidence Full-length transcript characterization and mutation sequencing in PCD patients

   PMID:11788826

   Open questions at the time

   • Did not resolve subcellular localization of mutant protein
   • Did not address embryonic mechanism of laterality
3. 2005 High

   Resolving where DNAH5 sits in the axoneme revealed regional ODA heterogeneity and showed that mutant protein mislocalizes to the MTOC, linking assembly failure to graded motility loss.

   Evidence High-resolution immunofluorescence of respiratory and sperm cells plus high-speed video microscopy

   PMID:15750039

   Open questions at the time

   • Mechanism of regional ODA targeting (proximal vs distal) not defined
   • Molecular basis of MTOC accumulation not established
4. 2006 High

   Large cohort genetics combined with EM and immunofluorescence quantified the mutational and ultrastructural footprint of DNAH5 deficiency, defining it as the predominant cause of ODA-defective PCD.

   Evidence Haplotype analysis and sequencing of 109 PCD families with electron microscopy and immunofluorescence

   PMID:16627867

   Open questions at the time

   • Functional consequences of mutation clustering in five exons not mechanistically explained
   • Proximal-only retention in one patient not generalized
5. 2006 Medium

   Showing that inflammation-induced secondary ciliary dyskinesia does not alter DNAH5 localization confirmed that mislocalization is a specific readout of the primary defect, validating it as a diagnostic marker.

   Evidence IL-13 induction of SCD in primary human airway cultures with videomicroscopy, EM, and immunofluorescence

   PMID:16492982

   Open questions at the time

   • Single lab
   • Did not test all inflammatory contexts
6. 2016 Medium

   Discovery of a TRA2B-DNAH5 fusion in lung squamous cell carcinoma revealed an oncogenic role distinct from ciliary motility, acting through a defined kinase signaling axis.

   Evidence Exon array, molecular analysis, and ERK1/2 inhibitor (selumetinib) treatment of fusion-expressing cell lines

   PMID:27670699

   Open questions at the time

   • Single lab
   • Contribution of native DNAH5 sequence to fusion function unclear
   • In vivo tumor dependence not fully established
7. 2019 High

   A Dnah5 mutant mouse pinned the laterality defect to immotile left-right organizer cilia, absent ODAs, lost leftward flow, and randomized Nodal signaling, closing the mechanistic loop from gene to embryonic asymmetry.

   Evidence High-speed video microscopy, immunofluorescence, and in situ hybridization in mutant mouse embryos with human genotype-phenotype correlation

   PMID:31638833

   Open questions at the time

   • Did not resolve why laterality outcome varies (normal/reversed/bilateral)
   • Upstream determinants of flow sensing not addressed
8. 2022 Medium

   An airway organoid multiomics study connected DNAH5-deficient cilia to dysregulated immune signaling via TGF-beta/BMP and Notch control of ciliated cell differentiation.

   Evidence DNAH5-mutant PCD patient airway organoid with scRNA-seq and proteomics

   PMID:36552777

   Open questions at the time

   • Single patient-derived model
   • Causal direction between ciliary defect and immune dysregulation not proven
   • Pathway link correlative

• The molecular determinants that target DNAH5 to proximal versus distal axonemal ODA subtypes, and the basis for variable laterality outcomes, remain unresolved.
• No structural model of DNAH5 within the ODA
• Mechanism of regional ODA assembly unknown
• Assembly factors directing axonemal vs MTOC localization not identified